BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21536130)

  • 21. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
    Kawakami K; Watanabe G
    Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity.
    Kawakami K; Ishida Y; Danenberg KD; Omura K; Watanabe G; Danenberg PV
    Jpn J Cancer Res; 2002 Nov; 93(11):1221-9. PubMed ID: 12460463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
    Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
    Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J
    Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
    J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas.
    Kristensen MH; Weidinger M; Bzorek M; Pedersen PL; Mejer J
    J Int Med Res; 2010; 38(2):484-97. PubMed ID: 20515563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases.
    Bendardaf R; Lamlum H; Ristamäki R; Korkeila E; Syrjänen K; Pyrhönen S
    Acta Oncol; 2008; 47(6):1046-53. PubMed ID: 17943475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
    Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
    Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.
    Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase pharmacogenetics in colorectal cancer.
    Marsh S; McLeod HL
    Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene.
    Uchida K; Hayashi K; Kawakami K; Schneider S; Yochim JM; Kuramochi H; Takasaki K; Danenberg KD; Danenberg PV
    Clin Cancer Res; 2004 Jan; 10(2):433-9. PubMed ID: 14760062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
    Edler D; Glimelius B; Hallström M; Jakobsen A; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    J Clin Oncol; 2002 Apr; 20(7):1721-8. PubMed ID: 11919227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.
    Graziano F; Ruzzo A; Loupakis F; Santini D; Catalano V; Canestrari E; Maltese P; Bisonni R; Fornaro L; Baldi G; Masi G; Falcone A; Tonini G; Giordani P; Alessandroni P; Giustini L; Vincenzi B; Magnani M
    Br J Cancer; 2008 Sep; 99(5):716-21. PubMed ID: 18728661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
    Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
    Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Sulzyc-Bielicka V; Bielicki D; Binczak-Kuleta A; Kaczmarczyk M; Pioch W; Machoy-Mokrzynska A; Ciechanowicz A; Gołębiewska M; Drozdzik M
    Genet Test Mol Biomarkers; 2013 Nov; 17(11):799-806. PubMed ID: 23968134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the polymorphisms of thymidylate synthase on cell-free circulating DNA in blood of patients with advanced colorectal carcinoma.
    Schwarzenbach H; Goekkurt E; Pantel K; Aust DE; Stoehlmacher J
    Int J Cancer; 2010 Aug; 127(4):881-8. PubMed ID: 19998340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells.
    Naghibalhossaini F; Shefaghat M; Mansouri A; Jaberi H; Tatar M; Eftekhar E
    Acta Med Iran; 2017 Dec; 55(12):751-758. PubMed ID: 29373881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.